🚨 Mr. Eazi just changed the conversation on the Ghana Stock Exchange. His company, Zagadat Capital, acquired a 17.36% stake in Intravenous Infusions Ltd (IIL) — and investors are already anticipating massive bids on Monday. This could be BIG for Ghana Alternative Market (GAX).